Early research (Phase 1)WithdrawnNCT03057990What this trial is testingPyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)Who this might be right forMyelodysplastic Syndromes Montefiore Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010What this trial is testingMenin-Inhibitor Targeted Maintenance in AMLWho this might be right forRelapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more Center for International Blood and Marrow Transplant Research 146
Testing effectiveness (Phase 2)Study completedNCT00085813What this trial is testingIspinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT01197560What this trial is testingStudy of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Celgene 111
Large-scale testing (Phase 3)Active Not RecruitingNCT06847724What this trial is testingComparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple SclerosisWho this might be right forRelapsing Multiple Sclerosis Sandoz 183
Early research (Phase 1)WithdrawnNCT01130623What this trial is testingA Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsWho this might be right forSarcomaNeuroblastomaWilms Tumor+2 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT04874480What this trial is testingTegavivint for the Treatment of Relapsed or Refractory LeukemiaWho this might be right forRecurrent LeukemiaRefractory Leukemia M.D. Anderson Cancer Center 9
Post-approval studies (Phase 4)UnknownNCT01758679What this trial is testingA Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular CarcinomaWho this might be right forMultiple Drug Use Tianjin Medical University Cancer Institute and Hospital 120
Early research (Phase 1)Looking for participantsNCT06799026What this trial is testingVaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma David Avigan 25
Not applicableStudy completedNCT02440126What this trial is testingLongitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML RiskWho this might be right forMultiple Sclerosis Rocky Mountain MS Research Group, LLC 196
Testing effectiveness (Phase 2)Study completedNCT00044018What this trial is testingCDC-501 Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 102
Early research (Phase 1)UnknownNCT04295018What this trial is testingBCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaWho this might be right forMultiple Myeloma Peking Union Medical College Hospital 10
Not applicableStudy completedNCT04847323What this trial is testingClinical Effectiveness of Bonded Versus Vacuum-formed RetainersWho this might be right forRelapse University of Sao Paulo 50
Testing effectiveness (Phase 2)Study completedNCT02509546What this trial is testing8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia City of Hope Medical Center 20
Early research (Phase 1)Study completedNCT01884935What this trial is testingPK and PD Study of Natalizumab in Pediatric Subjects With RRMSWho this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 13
Early research (Phase 1)Looking for participantsNCT05963217What this trial is testingStudy of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLWho this might be right forRelapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT00002474What this trial is testingCombination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian CancerWho this might be right forOvarian Cancer Loyola University
Not applicableUnknownNCT01440413What this trial is testingStudy of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast CancerWho this might be right forBreast Cancer Centre Leon Berard 40
Not applicableLooking for participantsNCT06678282What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ LeukemiaWho this might be right forB-NHLB-ALL Shenzhen Genocury Biotech Co., Ltd. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724782What this trial is testingMulti-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCLWho this might be right forPTCL-NOS Tianjin Medical University Cancer Institute and Hospital 33